This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $100,000
Effects of dexmedetomidine in patients with agitated delirium in palliative care: an open-label phase 1/2 proof-of-concept, feasibility, and dose-finding clinical trial
CIHR · 2020 · Principal investigator
- $19,716
Using patient-reported outcomes to improve the quality of palliative care: Establishing priorities and actions for data collection and reporting in Canada
CIHR · 2019 · Co-investigator
Effects of dexmedetomidine in patients with agitated delirium in palliative care: an open-label phase 1/2 proof-of-concept, feasibility, and dose-finding clinical trial
Principal investigators: Downar, James; Kanji, Salmaan; Lascelle, Debi; Lawlor, Peter G; Parsons, Henrique A
Keywords: Agitated Delirium; Dexmedetomidine; Palliative Care; Phase I/Ii Clinical Trial; Qualitative Investigation; Rousable Sedation
Using patient-reported outcomes to improve the quality of palliative care: Establishing priorities and actions for data collection and reporting in Canada
Principal investigators: Downar, James
Keywords: Data Standardization; Palliative Care; Patient-Centred Outcomes; Patient-Reported Outcomes
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.